The following has been reported: "primary administration set had continuous upstream occlusion.Would not infuse from secondary side with 250ml medication on a secondary set.Unable to back from the secondary side through set or into a 10 or 20ml infusion.No patient harm but did cause a delay in therapy starting due to troubleshooting." this issue delayed an active infusion, but it was completed.Reporting due to the referenced issue.No adverse effects to the patient were reported.More information is needed to complete the investigation.
|